Done ADHD Cost 2025–2026: $199/Month Telehealth for ADHD Explained

ADHD is diagnosed in an estimated 4.4% of U.S. adults — roughly 11 million people — according to NIMH data, yet a substantial share of them are undiagnosed or untreated. Done launched to address the access gap, offering ADHD-specific telehealth without a long wait for a psychiatric appointment.

The flat fee is $199/month. Here’s exactly what that covers, what it doesn’t, and the real-world limits you need to know about.

What $199/Month Gets You

Done’s subscription model is designed around a single condition: ADHD. Unlike platforms that handle depression, anxiety, and a dozen other conditions, Done focuses entirely on ADHD evaluation and management.

Medication costs are separate. Generic Adderall (amphetamine salts) typically runs $30–$60/month at major pharmacies. Vyvanse (lisdexamfetamine) brand runs $300–$400/month; a generic became available in 2023, bringing costs down to $60–$120/month depending on dose and pharmacy.

The Controlled Substance Reality

This is the most important section for any ADHD telehealth patient to understand.

Done prescribes Schedule II controlled substances — Adderall, Ritalin, Vyvanse, Focalin, and others. Under the DEA’s Ryan Haight Act, prescribing controlled substances via telehealth requires an in-person visit unless the DEA waives that requirement (as it did during the COVID-19 public health emergency).

The COVID-19 telehealth exceptions expired in 2025. That means:

In practice, many patients can still initiate treatment through Done in states that have their own telehealth prescribing allowances — but this landscape is shifting. Non-stimulant options (Strattera, Wellbutrin, Qelbree) don’t have the same restrictions and can be prescribed remotely.

Who Done Is Best For

Done is a specialized platform — it works best for a narrow but significant patient profile:

Good fit:

• Adults who’ve had prior ADHD diagnoses and need prescription management
• People in areas without accessible psychiatrists or psychiatric NPs
• Patients who want non-stimulant ADHD medication managed telehealth
• Anyone who just needs straightforward follow-up visits after an existing diagnosis

Not a good fit:

• Patients who need their first-ever formal ADHD evaluation with neuropsychological testing
• Anyone who also needs therapy or treatment for co-occurring depression or anxiety
• Patients in states where current DEA rules block telehealth stimulant prescribing

The Shortage Context

The U.S. has experienced ongoing Adderall and Ritalin shortages since 2022. FDA shortage tracking data shows disruptions affecting multiple manufacturers of amphetamine salts and methylphenidate products. This doesn’t affect Done specifically, but it means prescriptions from Done (or any provider) may be difficult to fill at your local pharmacy in some months.

Telehealth ADHD providers can’t fix a supply chain problem. If you’re starting ADHD treatment, build in some flexibility and consider asking about non-stimulant backups.

Comparing Done to Other ADHD Telehealth Options

Insurance

Done doesn’t currently accept insurance directly for subscriptions. However, they can provide a superbill — a detailed receipt with billing codes — that you can submit to your insurance for potential out-of-network reimbursement. Medication costs are separate and covered by pharmacy benefits as usual.

Bottom Line

Done’s $199/month subscription is a reasonable option for adult ADHD medication management — especially if you already have a diagnosis and just need ongoing prescriber support. The controlled substance issue is real and state-dependent; don’t assume stimulants are automatically available via telehealth in your state before you subscribe. For ADHD-plus-anxiety or ADHD-plus-depression, you’ll need to supplement with another provider or platform since Done doesn’t offer therapy.